Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hormonal therapies are safe and effective for treating adult women's acne.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Prolactin may affect hair growth differently based on gender and scalp area.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Moderately high prolactin levels do not cause hair loss in women.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.